S. 133, S. 134, S. 265, S. 1844, S. 1852, and S. 1855

• S. 133, NAPA Reauthorization Act 

• S. 134, Alzheimer’s Accountability and Investment Act  

• S. 265, SIREN Reauthorization Act   

• S. 1844, Animal Drug and Animal Generic Drug User Fee Amendments of 2023   

• S. 1852, Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2023 

• S. 1855, Special Diabetes Program Reauthorization Act of 2023 

• Any additional business for consideration

Click here to view Manager’s Amendment for S. 133, NAPA Reauthorization Act

Click here to view Manager’s Amendment for S. 265, SIREN Reauthorization Act   

Click here to view Sen. Marshall's Amendment to S. 1844